Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms: HELP
Articles by Mahmoud M. Al-Hawary
Based on 9 articles published since 2008
||||

Between 2008 and 2019, Mahmoud Al-Hawary wrote the following 9 articles about Pancreatic Neoplasms.
 
+ Citations + Abstracts
1 Guideline Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 2017

Tempero, Margaret A / Malafa, Mokenge P / Al-Hawary, Mahmoud / Asbun, Horacio / Bain, Andrew / Behrman, Stephen W / Benson, Al B / Binder, Ellen / Cardin, Dana B / Cha, Charles / Chiorean, E Gabriela / Chung, Vincent / Czito, Brian / Dillhoff, Mary / Dotan, Efrat / Ferrone, Cristina R / Hardacre, Jeffrey / Hawkins, William G / Herman, Joseph / Ko, Andrew H / Komanduri, Srinadh / Koong, Albert / LoConte, Noelle / Lowy, Andrew M / Moravek, Cassadie / Nakakura, Eric K / O'Reilly, Eileen M / Obando, Jorge / Reddy, Sushanth / Scaife, Courtney / Thayer, Sarah / Weekes, Colin D / Wolff, Robert A / Wolpin, Brian M / Burns, Jennifer / Darlow, Susan. · ·J Natl Compr Canc Netw · Pubmed #28784865.

ABSTRACT: Ductal adenocarcinoma and its variants account for most pancreatic malignancies. High-quality multiphase imaging can help to preoperatively distinguish between patients eligible for resection with curative intent and those with unresectable disease. Systemic therapy is used in the neoadjuvant or adjuvant pancreatic cancer setting, as well as in the management of locally advanced unresectable and metastatic disease. Clinical trials are critical for making progress in treatment of pancreatic cancer. The NCCN Guidelines for Pancreatic Adenocarcinoma focus on diagnosis and treatment with systemic therapy, radiation therapy, and surgical resection.

2 Review Optimal Imaging Modalities for the Diagnosis and Staging of Periampullary Masses. 2016

Al-Hawary, Mahmoud M / Kaza, Ravi K / Francis, Isaac R. ·Department of Radiology, University Hospital, University of Michigan, Room B1 D502, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. Electronic address: alhawary@med.umich.edu. · Department of Radiology, University Hospital, University of Michigan, Room B1 D501, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. · Department of Radiology, University Hospital, University of Michigan, Room B1 D540, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. ·Surg Oncol Clin N Am · Pubmed #27013362.

ABSTRACT: Imaging plays a central role in the management of patients with suspected or known periampullary masses, including the initial diagnosis, staging, and follow-up to assess treatment response or recurrence. Use of appropriate imaging tools, application of optimal imaging protocols, and knowledge about imaging findings are essential for the diagnosis and accurate staging of these masses. Structured reporting of the imaging studies offers several advantages over freestyle dictations ensuring completeness of the relevant imaging findings, which would in turn help in deciding the best individual treatment strategy for each patient.

3 Review Pancreatic Solid and Cystic Neoplasms: Diagnostic Evaluation and Intervention. 2015

Al-Hawary, Mahmoud M / Francis, Isaac R / Anderson, Michelle A. ·Division of Abdominal Imaging, Department of Radiology, University of Michigan Hospitals, 1500 East Medical Center Drive, Room B1 D502, Ann Arbor, MI 48109, USA. Electronic address: alhawary@med.umich.edu. · Division of Abdominal Imaging, Department of Radiology, University of Michigan Hospitals, 1500 East Medical Center Drive, Room B1 D540, Ann Arbor, MI 48109, USA. · Division of Gastroenterology, Department of Internal Medicine, University of Michigan Hospitals, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. ·Radiol Clin North Am · Pubmed #26321452.

ABSTRACT: High-resolution imaging modalities, such as multi-detector computed tomography, MR imaging, and endoscopic ultrasound, are frequently used alone or in combination to characterize focal solid and cystic pancreatic neoplasms. Imaging in solid pancreatic neoplasms, typically adenocarcinoma and neuroendocrine tumors, is primarily used to detect and stage the extent of the tumor and to determine if complete surgical resection for cure is feasible. In cystic pancreatic masses, imaging aims to differentiate benign nonmucinous cystic lesions from potentially or frankly malignant mucin-producing cysts. Several noninvasive and invasive treatment options can be performed if surgical resection is not possible or contraindicated.

4 Review Pancreatic ductal adenocarcinoma staging. 2013

Al-Hawary, Mahmoud M / Francis, Isaac R. ·Department of Radiology, University of Michigan Health Services, Ann Arbor, MI, USA. ·Cancer Imaging · Pubmed #24060977.

ABSTRACT: In addition to clinical history and evaluations, the results of laboratory tests and imaging studies help clinicians in determining treatment strategies. Imaging plays a central role in the management of oncology patients including the initial diagnosis, staging, and follow-up to assess treatment response. Historically, radiologists have relied on free-style dictations to convey the results of imaging findings in radiology reports to referring clinicians. These unstructured free-style dictations can potentially be a source of frustration as the pertinent information needed to guide treatment may be omitted or difficult to extract from the report, thereby limiting its completeness and usefulness. These limitations can be overcome by adopting a structured and reproducible form of reporting imaging studies to help clinicians in deciding the best treatment strategy for each patient. There is a growing need to establish standardized radiology reporting templates for specific disease processes. One such example involves patients with pancreatic ductal adenocarcinoma, as imaging findings determine the treatment arm to which the patient is assigned. In this presentation, we outline a list of essential features that need to be included in a structured report and highlight this with illustrative case examples.

5 Review Mimics of pancreatic ductal adenocarcinoma. 2013

Al-Hawary, Mahmoud M / Kaza, Ravi K / Azar, Shadi F / Ruma, Julie A / Francis, Isaac R. ·Department of Radiology, University of Michigan Health Services, Ann Arbor, MI, USA. ·Cancer Imaging · Pubmed #24060833.

ABSTRACT: Several uncommon primary pancreatic tumors, inflammatory conditions, metastasis to the pancreas and peripancreatic masses can mimic the appearance of pancreatic ductal adenocarcinoma (PDA). Differentiation between these lesions and PDA can be challenging, due to the overlap in imaging features; however, familiarity with their typical imaging features and clinical presentation may be helpful in their differentiation, as in some cases, invasive diagnostic tests or unnecessary surgery can be avoided. The different pathologies that can mimic PDA include inflammatory conditions such as the various forms of pancreatitis (chronic-focal mass-forming, autoimmune and groove pancreatitis), pancreatic neuroendocrine tumors, solid pseudopapillary tumors, metastasis (solid non-lymphomatous and hematologic), congenital variants (annular pancreas), as well as peripancreatic lesions (accessory spleen, adrenal masses, duodenal masses, lymph nodes and vascular lesions), and certain rare pancreatic tumors (e.g., acinar cell tumors, solid serous tumors, hamartoma and solitary fibrous tumors). The clinical presentation and imaging features of the most commonly encountered mimics of PDA are discussed in this presentation with representative illustrations.

6 Review Staging of pancreatic cancer: role of imaging. 2013

Al-Hawary, Mahmoud M / Kaza, Ravi K / Wasnik, Ashish P / Francis, Isaac R. ·Diagnostic Radiology, Abdominal Imaging Division, University of Michigan, University Hospital, Ann Arbor, MI 48109, USA. alhawary@med.umich.edu ·Semin Roentgenol · Pubmed #23796375.

ABSTRACT: -- No abstract --

7 Article Role of Imaging in Diagnosing and Staging Pancreatic Cancer. 2016

Al-Hawary, Mahmoud. ·Presented by Mahmoud Al-Hawary, MD, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. ·J Natl Compr Canc Netw · Pubmed #27226513.

ABSTRACT: Imaging is a key component of diagnosis and staging of pancreatic cancer. CT, MRI, and endoscopic ultrasound are the most used and approved imaging modalities. The updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma feature a recently published Pancreatic Ductal Adenocarcinoma Radiology Reporting Template endorsed by the Society of Abdominal Radiology and the American Pancreatic Association. The goal of the template is to standardize the reporting of the imaging findings and to improve communication among the various team members treating patients with pancreatic cancer, to ensure appropriate patient management.

8 Article Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. 2014

Al-Hawary, Mahmoud M / Francis, Isaac R / Chari, Suresh T / Fishman, Elliot K / Hough, David M / Lu, David S / Macari, Michael / Megibow, Alec J / Miller, Frank H / Mortele, Koenraad J / Merchant, Nipun B / Minter, Rebecca M / Tamm, Eric P / Sahani, Dushyant V / Simeone, Diane M. · ·Gastroenterology · Pubmed #24355035.

ABSTRACT: Pancreatic ductal adenocarcinoma is an aggressive malignancy with a high mortality rate. Proper determination of the extent of disease on imaging studies at the time of staging is one of the most important steps in optimal patient management. Given the variability in expertise and definition of disease extent among different practitioners as well as frequent lack of complete reporting of pertinent imaging findings at radiologic examinations, adoption of a standardized template for radiology reporting, using universally accepted and agreed on terminology for solid pancreatic neoplasms, is needed. A consensus statement describing a standardized reporting template authored by a multi-institutional group of experts in pancreatic ductal adenocarcinoma that included radiologists, gastroenterologists, and hepatopancreatobiliary surgeons was developed under the joint sponsorship of the Society of Abdominal Radiologists and the American Pancreatic Association. Adoption of this standardized imaging reporting template should improve the decision-making process for the management of patients with pancreatic ductal adenocarcinoma by providing a complete, pertinent, and accurate reporting of disease staging to optimize treatment recommendations that can be offered to the patient. Standardization can also help to facilitate research and clinical trial design by using appropriate and consistent staging by means of resectability status, thus allowing for comparison of results among different institutions.

9 Article Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. 2014

Al-Hawary, Mahmoud M / Francis, Isaac R / Chari, Suresh T / Fishman, Elliot K / Hough, David M / Lu, David S / Macari, Michael / Megibow, Alec J / Miller, Frank H / Mortele, Koenraad J / Merchant, Nipun B / Minter, Rebecca M / Tamm, Eric P / Sahani, Dushyant V / Simeone, Diane M. ·From the Departments of Radiology (M.M.A., I.R.F.), Surgery (R.M.M., D.M.S.), and Molecular and Integrative Physiology (D.M.S.), University of Michigan Health System, 1500 E Medical Center Dr, University Hospital, Room B1 D502, Ann Arbor, MI 48109 · Departments of Internal Medicine (S.T.C.) and Radiology (D.M.H.), Mayo Clinic, Rochester, Minn · Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, Md (E.K.F.) · Department of Radiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, Calif (D.S.L.) · Department of Radiology, New York University Medical Center, New York, NY (M.M., A.J.M.) · Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Ill (F.H.M.) · Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass (K.J.M.) · Department of Surgery, Vanderbilt University, Nashville, Tenn (N.B.M.) · Department of Radiology, University of Texas-MD Anderson Cancer Center, Houston, Tex (E.P.T.) · and Department of Radiology, Massachusetts General Hospital, Boston, Mass (D.V.S.). ·Radiology · Pubmed #24354378.

ABSTRACT: Pancreatic ductal adenocarcinoma is an aggressive malignancy with a high mortality rate. Proper determination of the extent of disease on imaging studies at the time of staging is one of the most important steps in optimal patient management. Given the variability in expertise and definition of disease extent among different practitioners as well as frequent lack of complete reporting of pertinent imaging findings at radiologic examinations, adoption of a standardized template for radiology reporting, using universally accepted and agreed on terminology for solid pancreatic neoplasms, is needed. A consensus statement describing a standardized reporting template authored by a multi-institutional group of experts in pancreatic ductal adenocarcinoma that included radiologists, gastroenterologists, and hepatopancreatobiliary surgeons was developed under the joint sponsorship of the Society of Abdominal Radiologists and the American Pancreatic Association. Adoption of this standardized imaging reporting template should improve the decision-making process for the management of patients with pancreatic ductal adenocarcinoma by providing a complete, pertinent, and accurate reporting of disease staging to optimize treatment recommendations that can be offered to the patient. Standardization can also help to facilitate research and clinical trial design by using appropriate and consistent staging by means of resectability status, thus allowing for comparison of results among different institutions.